12:00 AM
 | 
Dec 10, 2012
 |  BC Week In Review  |  Company News  |  Deals

Ventria deal

Ventria acquired exclusive, royalty-free rights in the U.S., France and Canada to undisclosed patents related to recombinant human

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >